Valeant Pharmaceuticals Intl (VRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | SMMT | MDGL | ||
| Company | Valeant Pharmaceuticals Intl | Summit Therapeu ADR | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 24.15 | 17.97 | 310.81 | ||
| High | 24.43 | 18.90 | 311.18 | ||
| Low | 23.36 | 17.61 | 302.16 | ||
| Last | 23.40 | 18.67 | 310.87 | ||
| Change | -0.83 | +0.80 | +2.43 | ||
| % Change | -3.43% | +4.48% | +0.79% | ||
| Volume | 6,569,300 | 2,276,500 | 235,900 | ||
| 20-Day Average Volume | 6,685,200 | 2,263,425 | 340,630 | ||
| Previous Close | 24.23 | 17.87 | 308.44 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 18.30 | 315.06 | ||
| 20-Day Raw Stochastic | 18.46% | 71.19% | 33.98% | ||
| 20-Day Relative Strength | 52.09% | 49.63% | 53.76% | ||
| Weighted Alpha | +35.20 | +35.89 | +2.14 | ||
| Today's Opinion | N/A | 40% Buy | 80% Buy | ||
| Previous Opinion | N/A | 24% Buy | 80% Buy | ||
| Last Month's Opinion | N/A | 40% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | -0.05% since 12/16/24 | -0.04% since 12/16/24 | ||
| Low | 23.02 on 07/09/18 | 16.83 on 12/18/24 | 289.80 on 12/18/24 | ||
| High | 24.43 on 07/13/18 | 19.18 on 12/17/24 | 315.09 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | -1.74% since 11/22/24 | -10.53% since 11/22/24 | ||
| Low | 22.56 on 06/28/18 | 16.52 on 12/03/24 | 289.80 on 12/18/24 | ||
| High | 27.25 on 06/14/18 | 19.54 on 11/26/24 | 351.80 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | -14.79% since 09/23/24 | +37.72% since 09/23/24 | ||
| Low | 16.76 on 04/16/18 | 16.52 on 12/03/24 | 200.63 on 10/23/24 | ||
| High | 27.79 on 06/13/18 | 24.84 on 09/25/24 | 368.29 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +135.44% since 06/21/24 | +11.66% since 06/21/24 | ||
| Low | 14.44 on 03/02/18 | 6.78 on 07/03/24 | 200.63 on 10/23/24 | ||
| High | 27.79 on 06/13/18 | 33.89 on 09/16/24 | 368.29 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 13,178,196 | 6,727,073 | ||
| Shares Outstanding, K | 348,710 | 737,448 | 21,810 | ||
| Annual Sales | 8,724,000,000 | 0 | 0 | ||
| Annual Net Income | 2,404,000,000 | -614,930,000 | -373,630,000 | ||
| Last Quarter Sales | 1,995,000,000 | 0 | 62,180,000 | ||
| Last Quarter Net Income | -2,693,000,000 | -56,250,000 | -106,960,000 | ||
| 60-Month Beta | -0.38 | -0.92 | -0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | -0.08 on 10/30/24 | -4.92 on 10/31/24 | ||
| Latest Earnings Date | 08/14/18 | 10/30/24 | 10/31/24 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 0.00 | 0.00 | ||